tldrdailynews.com logo

Moderna's 2025 Revenue Outlook Reduced Amid Shipment Delays and Earnings Watch

1 min read
Source: CNBC
Moderna's 2025 Revenue Outlook Reduced Amid Shipment Delays and Earnings Watch
Photo: CNBC
TL;DR

Moderna lowered its 2025 revenue forecast due to a delay in vaccine shipments to the UK but exceeded Wall Street expectations for Q2, posting a smaller loss and higher revenue driven mainly by Covid vaccine sales, while also implementing cost cuts and workforce reductions.

Topics:top-newsbusiness#business#cost-cutting#moderna#q2-earnings#revenue-outlook#vaccine-shipment-delay
Share this article
  1. Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.  CNBC
  2. Moderna Logs Sales Beat Despite Declining Vaccine Demand  The Wall Street Journal
  3. Moderna’s Loss Narrows After Cost-Cutting Efforts Take Hold (MRNA)  Bloomberg
  4. Moderna to Report Earnings as Cash Balance Shrinks  Barron's
  5. Moderna Earnings: What To Look For From MRNA  Yahoo Finance

Want the full story? Read the original reporting

Read on CNBC